Meridian Bioscience's Q2 Revenues Rise 16 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Meridian Bioscience today reported second-quarter revenue growth of 16 percent with double-digit growth for its life science and US diagnostics business.

The Cincinnati-based diagnostics firm reported total revenues of $47.4 million for the three-month period ended March 31, up 16 percent from $41.1 million for the first quarter of 2011. It beat the consensus Wall Street estimate of $44.8 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.

In Genome Biology this week: comparative genomics study of Aspergillus, genetic variation in indigenous African cattle, and more.

Some people who harbor genetic variants associated with disease show no signs and may give insight into the continuum of symptoms, Spectrum reports.